Ajanta Pharma Q1 Results
- BSE: 532331
- NSE: AJANTPHARM
- ISIN: INE031B01049
- Sector: Biotechnology & Drugs
BSE
3,597.25
84.75 (2.41%)
84.75 (2.41%)Volume2.99 K
Updated: Tue 8 Sep, 2026 | 15:29:22
NSE
3,58975.40 (2.15%)
75.40 (2.15%)Volume1.13 L
Updated: Tue 8 Sep, 2026 | 15:30:03
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q1 Results Highlights
- Total Income₹1,625.96 Cr.(24.82%)
- Operating Profit₹409.67 Cr.(22.21%)
- Profit After Tax₹334.22 Cr.(30.89%)
- Operating Margin25.20%(-2.09%)
Note: Comparison is on YoY basis
Quarterly - Ajanta Pharma Q1 Results
*All figures in crores except per share values
| Fiscal Period | Jun 26 | Mar 26 | QoQ Comp | Jun 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 1,216.29 | 1,133.60 | 7.29% | 848.54 | 25.72% |
| Depreciation/ Amortization | 44.50 | 45.37 | -1.92% | 33.97 | 7.77% |
| Operating Income | 409.67 | 288.04 | 42.23% | 296.38 | 22.21% |
| Net Income | 334.22 | 266.70 | 25.32% | 245.77 | 30.89% |
| Other Operating Expenses Total | 462.83 | 442.70 | 4.55% | 262.94 | 33.24% |
| Net Income Before Taxes | 446.80 | 347.11 | 28.72% | 322.12 | 34.93% |
| Total Revenue | 1,625.96 | 1,421.64 | 14.37% | 1,144.92 | 24.82% |
| Selling/ General/ Admin Expenses Total | 381.11 | 340.72 | 11.85% | 283.78 | 25.82% |
| Diluted Normalized EPS | 26.75 | 21.34 | 25.34% | 19.53 | 30.93% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.